Guangzhou Wondfo Biotech Co Ltd Cash Flow Conversion Efficiency
Guangzhou Wondfo Biotech Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Guangzhou Wondfo Biotech Co Ltd (300482) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥116.99 Million ≈ $17.12 Million USD) by net assets (CN¥5.56 Billion ≈ $813.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Guangzhou Wondfo Biotech Co Ltd (2011–2025)
Cash flow conversion efficiency of Guangzhou Wondfo Biotech Co Ltd from 2011 to 2025. This chart illustrates how Guangzhou Wondfo Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Guangzhou Wondfo Biotech Co Ltd (300482) share price today for real-time trading data and today's change.
Guangzhou Wondfo Biotech Co Ltd Cash Flow Conversion Ratio Explained
Guangzhou Wondfo Biotech Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Guangzhou Wondfo Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guangzhou Wondfo Biotech Co Ltd ranked by their cash flow conversion efficiency. Also see Guangzhou Wondfo Biotech Co Ltd (300482) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Perella Weinberg Partners
NASDAQ:PWP
|
0.185x |
|
Shenzhen Sunline Tech Co Ltd
SHE:300348
|
-0.013x |
|
Valeura Energy Inc
TO:VLE
|
0.212x |
|
Nanfang Pump Industry
SHE:300145
|
0.063x |
|
EMTEK (Shenzhen) Co. Ltd.
SHE:300938
|
N/A |
|
C*Core Technology Co Ltd
SHG:688262
|
0.051x |
|
Marcus & Millichap Inc
NYSE:MMI
|
0.048x |
|
Vinati Organics Limited
NSE:VINATIORGA
|
0.122x |
Annual Cash Flow Conversion Efficiency for Guangzhou Wondfo Biotech Co Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of Guangzhou Wondfo Biotech Co Ltd from 2011 to 2025. Review how much free cash does Guangzhou Wondfo Biotech Co Ltd generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥5.47 Billion ≈ $800.95 Million |
CN¥463.04 Million ≈ $67.76 Million |
0.085x | +32.15% |
| 2024-12-31 | CN¥5.65 Billion ≈ $826.81 Million |
CN¥361.71 Million ≈ $52.93 Million |
0.064x | -23.90% |
| 2023-12-31 | CN¥4.61 Billion ≈ $675.26 Million |
CN¥388.19 Million ≈ $56.80 Million |
0.084x | -77.31% |
| 2022-12-31 | CN¥4.54 Billion ≈ $663.99 Million |
CN¥1.68 Billion ≈ $246.15 Million |
0.371x | +95.36% |
| 2021-12-31 | CN¥3.50 Billion ≈ $512.76 Million |
CN¥664.93 Million ≈ $97.30 Million |
0.190x | -46.50% |
| 2020-12-31 | CN¥2.99 Billion ≈ $438.06 Million |
CN¥1.06 Billion ≈ $155.38 Million |
0.355x | +181.66% |
| 2019-12-31 | CN¥2.46 Billion ≈ $360.06 Million |
CN¥309.86 Million ≈ $45.34 Million |
0.126x | +9.42% |
| 2018-12-31 | CN¥2.15 Billion ≈ $314.82 Million |
CN¥247.61 Million ≈ $36.23 Million |
0.115x | -18.89% |
| 2017-12-31 | CN¥1.19 Billion ≈ $174.13 Million |
CN¥168.85 Million ≈ $24.71 Million |
0.142x | +8.28% |
| 2016-12-31 | CN¥854.75 Million ≈ $125.08 Million |
CN¥112.01 Million ≈ $16.39 Million |
0.131x | -30.35% |
| 2015-12-31 | CN¥700.64 Million ≈ $102.53 Million |
CN¥131.81 Million ≈ $19.29 Million |
0.188x | -43.56% |
| 2014-12-31 | CN¥313.43 Million ≈ $45.86 Million |
CN¥104.47 Million ≈ $15.29 Million |
0.333x | -20.24% |
| 2013-12-31 | CN¥241.47 Million ≈ $35.33 Million |
CN¥100.91 Million ≈ $14.77 Million |
0.418x | +1.91% |
| 2012-12-31 | CN¥182.48 Million ≈ $26.70 Million |
CN¥74.84 Million ≈ $10.95 Million |
0.410x | +148.81% |
| 2011-12-31 | CN¥144.61 Million ≈ $21.16 Million |
CN¥23.83 Million ≈ $3.49 Million |
0.165x | -- |
About Guangzhou Wondfo Biotech Co Ltd
Guangzhou Wondfo Biotech Co.,Ltd, an in vitro diagnostics company, engages in the research and development, production, market, sale, and service of vitro diagnostic products in China. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious disease, fertility, tumor marker, and sexually transmitted diseases; immunofluorescence platform for detecting cardiac, thyroid, rhe… Read more